Pay in 4 interest-free payments of $6.33 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
1 Deal Highlights $75 million upfront payment Up to $1.185 billion in development, regulatory and commercial milestones Royalties on future sales Eli Lilly and Company receives worldwide rights excluding Korea The deal carries a potential value of approximately $1.26 billion and further validates Hanmis long-acting biologics platform
Key features of the current landscape: Academic and biotech interest has advanced the compound from early preclinical to translational work Licensed Healthcare Practitioners 1,000+ physician-grade products, bulk-tier pricing, and direct shipping to your practice
The error is extending this logic to claim capsules are equally effective as injection for tendon repair or brain health
This finding led to a boxed warning on GLP-1 medications regarding the risk of thyroid C-cell tumors
Holding the incretin background constant and varying the added receptor is how a design attributes an observed effect to a specific pathway
Storage requirements that prevent degradation
US$ 24.89
US$ 22.70
US$ 28.49
US$ 24.21
US$ 24.71
US$ 22.71
US$ 24.65
US$ 26.20
